Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Cushings Syndrome Clinical Trials
Cushings Syndrome clinical trials are recruiting across 15 cities. Here are the cities with the most active studies:
Cushings Syndrome Trial Phases
11 research organizations are sponsoring cushings syndrome trials.
About Cushings Syndrome
Cushing's syndrome results from prolonged exposure to high levels of the hormone cortisol, either from the body's own overproduction or from corticosteroid medications. Symptoms include weight gain, skin changes, and metabolic complications. Treatment depends on the cause and may include surgery, radiation, or medication.
Clinical trials are advancing new treatments for cushings syndrome. Currently, 12 studies are recruiting a combined 1,905 participants across the United States. Research is being conducted by 11 organizations including Mayo Clinic, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Memorial Sloan Kettering Cancer Center and 8 others.
2026 Cushings Syndrome Research Landscape
As of July 2026, the cushings syndrome clinical trial landscape includes 12 actively recruiting studies across 15 cities in the United States. These studies are collectively seeking 1,905 participants, with an average enrollment target of 159 per study.
The research spans multiple phases of development: 6 studies are in PHASE2, 1 study is in EARLY_PHASE1, 1 study is in NA, 1 study is in PHASE1. Early-phase studies suggest new therapeutic approaches are being explored for cushings syndrome.
Research is being led by 11 different organizations, including Mayo Clinic, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Memorial Sloan Kettering Cancer Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Neurological Disorders and Stroke (NINDS), and 6 others. The large number of sponsors reflects significant research interest and investment in cushings syndrome treatment advancement.
Geographically, cushings syndrome trials are most concentrated in Bethesda, Maryland (5 trials); Rochester, Minnesota (2 trials); Los Angeles, California (2 trials); Ann Arbor, Michigan (2 trials); Basking Ridge, New Jersey (1 trial) and 7 other cities.
Featured Cushings Syndrome Studies
Highlighted recruiting studies for cushings syndrome, selected by enrollment size and research scope.
Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)
Cushing syndrome (CS) is an endocrine disorder caused by chronic exposure to glucocorticoid (GC) excess. Endogenous CS has an estimated incidence of 0.2 to 5.0 cases per million per year and prevalence of 39 to 79 cases per million in various populations. CS usually affects young women, with a median age at diagnosis of 41.4 with a female-to-male ratio of 3:1. Following a curative surgery for CS, ...
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
Background: The pituitary gland produces hormones. A tumor in this gland can cause it to produce too much of the hormone cortisol. Too much cortisol in the body causes Cushing disease. This disease causes many problems. Some of these problems might persist after the disease is cured. Objective: To find out the long-term effects of exposure to high levels of cortisol during childhood and adolesc...
Collecting Information About Treatment Results for Patients With Cushing's Syndrome
The purpose of this study is to follow participants with Cushing's syndrome during the course of their routine care and to form a data registry to study long term participant outcomes.
Frequently Asked Questions About Cushings Syndrome Clinical Trials
Are there cushings syndrome clinical trials near me?
Yes, there are 12 cushings syndrome clinical trials currently recruiting across 15+ cities in the United States, including Bethesda, Maryland; Rochester, Minnesota; Los Angeles, California. Browse the studies above to find one at a location convenient for you.
How do I join a cushings syndrome clinical trial?
To join a cushings syndrome clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are cushings syndrome clinical trials free?
Yes, participation in cushings syndrome clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of cushings syndrome treatments are being studied?
Current cushings syndrome clinical trials are testing a range of approaches across PHASE2 (6 studies), EARLY_PHASE1 (1 study), NA (1 study), PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 11 research organizations.
Is it safe to participate in cushings syndrome clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov